rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Lunai Bioworks Inc.

LNAI · Nasdaq

Health CareBiotechnologyNot moving yet

LNAI stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 78.9% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−12 points in four weeks); Health Care: 28% (−6 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
18% -12 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
14 (-6)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

22 Apr – 21 Oct
16%27%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders14-6 on the quarter
New · exited6 · 14
Reported value$476K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Ground Swell Capital, LLCnew · filed 5 Aug 202653,211$174K+53,211
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 202624,156$79K-158,081−86.7%
JANE STREET GROUP, LLCnew · filed 14 Aug 202623,683$77K+23,683
VANGUARD CAPITAL MANAGEMENT LLCnew · filed 13 Aug 202616,081$53K+16,081
BlackRock, Inc.reduced · filed 7 Aug 202615,906$52K-111,408−87.5%
VANGUARD FIDUCIARY TRUST COnew · filed 13 Aug 20268,642$28K+8,642
Tower Research Capital LLC (TRC)reduced · filed 11 Aug 20261,405$4,594-3,298−70.1%
GROUP ONE TRADING LLCreduced · filed 14 Aug 2026544$1,779-3,816−87.5%
MORGAN STANLEYreduced · filed 13 Aug 2026326$1,066-2,288−87.5%
COMPASS FINANCIAL MANAGEMENT LLCnew · filed 12 Aug 2026125$409+125
30 Sep 2025 – 30 Jun 2026
111722Sep 25Dec 25Mar 26Jun 26

News

No headline names it lately.

Everyone who traded it

Anderson Wittekind William Company insider10% owner · last 10 Mar 20250 · 15
Nathen Fuentes Company insiderChief Financial Officer · last 21 Jan 20250 · 0
Tilburg Maurice Van Company insiderDirector · last 21 Jan 20250 · 0
Douglas W. Calder Company insiderDirector · last 4 Nov 20240 · 0
James A. McNulty Company insiderDirector · last 4 Nov 20240 · 0
Mark Anthony Collins Company insiderDirector · last 4 Nov 20240 · 0
Simon Tarsh Company insiderInterim CFO · last 4 Nov 20240 · 0
David Hershel Weinstein Company insiderChief Executive Officer · last 14 Oct 20240 · 0
Avram Miller Company insiderDirector · last 23 Aug 20240 · 0
Karen Brink Company insiderDirector, 10% owner · last 12 Aug 20240 · 0
Carol L. Brosgart Company insiderDirector · last 25 Jun 20240 · 0
Gregg H. Alton Company insiderDirector · last 25 Jun 20240 · 0

Same industry

MRNA ModernaLeading+168%
IOVA Iovance BiotherapeuticsLeading+134%
ABCL AbCellera BiologicsLeading+62%
ENTX Entera BioLeading+53%
HALO Halozyme TherapeuticsLeading+48%
XERS Xeris Biopharma HoldingsLeading+42%
XNCR XencorLeading+41%
HELP Helus PharmaLeading+37%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Research spendFY 2026 · to 30 Jun 202647.2%
Share count trendFY 2026 · to 13 Oct 20269.1%
Cash and equivalentsFY 2026 · to 30 Jun 2026$1.7M
Free cash flowFY 2026 · to 30 Jun 2026−$5.3M

Analyst forecasts

No analyst forecasts yet.